Literature DB >> 7515557

Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells.

G Mechtersheimer1, T Barth, A Quentmeier, P Möller.   

Abstract

Integrins are a superfamily of transmembrane alpha beta heterodimers that play an important role in cell-matrix and cell-cell interactions by acting as receptors for extracellular matrix proteins and for cell adhesion molecules. Using monoclonal antibodies against beta 1, alpha 1 to alpha 6, and alpha v subunits, the in situ distribution pattern of beta 1 integrins was examined immunohistochemically in nonneoplastic smooth and striated muscle cells and in their tumors. Nonneoplastic smooth muscle cells were beta 1+, alpha 1+, alpha 3+, alpha v+ and, in diverse localizations, also alpha 5+ or even alpha 6+. The expression of the beta 1 chain was conserved in all leiomyomas and leiomyosarcomas. The distribution pattern of the alpha subunits by contrast underwent several changes during malignant transformation of smooth muscle cells. These alterations consisted in a neoexpression of alpha 2, alpha 4, and alpha 6 as well as in an abnormal abrogation of alpha 1 and alpha 3 in some leiomyosarcomas. Except for the absence of alpha 5 in the majority of epithelioid leiomyosarcomas, expression of the alpha 5 and alpha v subunits was mainly conserved. In addition, tumors with epithelioid differentiation differed from typical cases by the absence of alpha 1 and the simultaneous presence of alpha 4. Adult striated muscle cells were beta 1+ but alpha 1- to alpha 6- and alpha v-, whereas fetal striated muscle cells were not only beta 1+ but also alpha 3+/-, alpha 4+/-, alpha 5+ and alpha 6+. In all rhabdomyosarcomas the expression of beta 1 was retained. Furthermore, the majority of cases showed the expression of one or more alpha subunits most of which, ie, alpha 4, alpha 5, and alpha 6, were also found in fetal striated muscle cells. In conclusion, beta 1 integrins exhibited a differential expression pattern along the two lines of myogenic differentiation. This integrin profile underwent characteristic changes during malignant transformation. Nevertheless, the compiled distribution patterns of the alpha 1, alpha 3, and alpha v subunits allowed in most instances the discrimination between tumors of smooth (alpha 1+/alpha 3+/alpha v+) and striated muscle (alpha 1-/alpha 3-/alpha v-) differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515557      PMCID: PMC1887445     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis.

Authors:  G D Rosen; J R Sanes; R LaChance; J M Cunningham; J Roman; D C Dean
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization.

Authors:  F Sánchez-Madrid; M O De Landázuri; G Morago; M Cebrián; A Acevedo; C Bernabeu
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

3.  Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells.

Authors:  J E de Vries; G D Keizer; A A te Velde; A Voordouw; D Ruiter; P Rümke; H Spits; C G Figdor
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

4.  Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor.

Authors:  R Pytela; M D Pierschbacher; E Ruoslahti
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

5.  The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells.

Authors:  M Amiot; A Bernard; H C Tran; G Leca; J M Kanellopoulos; L Boumsell
Journal:  Scand J Immunol       Date:  1986-01       Impact factor: 3.487

6.  VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation.

Authors:  M E Hemler; J G Jacobson; M B Brenner; D Mann; J L Strominger
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

7.  Cell matrix adhesion-related proteins VLA-1 and VLA-2: regulation of expression on T cells.

Authors:  M E Hemler; J G Jacobson
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

8.  Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody.

Authors:  S Zylstra; F A Chen; S K Ghosh; E A Repasky; U Rao; H Takita; R B Bankert
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

Authors:  Y Fradet; C Cordon-Cardo; T Thomson; M E Daly; W F Whitmore; K O Lloyd; M R Melamed; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Molecular forms of N-CAM and its RNA in developing and denervated skeletal muscle.

Authors:  J Covault; J P Merlie; C Goridis; J R Sanes
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

View more
  13 in total

1.  The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization.

Authors:  P J Gotwals; G Chi-Rosso; V Lindner; J Yang; L Ling; S E Fawell; V E Koteliansky
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

2.  Integrin β1 regulates leiomyoma cytoskeletal integrity and growth.

Authors:  Minnie Malik; James Segars; William H Catherino
Journal:  Matrix Biol       Date:  2012-09-26       Impact factor: 11.583

Review 3.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation.

Authors:  K Sobue; K Hayashi; W Nishida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  An essential requirement for β1 integrin in the assembly of extracellular matrix proteins within the vascular wall.

Authors:  Kirsten A Turlo; Onika D V Noel; Roshni Vora; Marie LaRussa; Reinhard Fassler; Faith Hall-Glenn; M Luisa Iruela-Arispe
Journal:  Dev Biol       Date:  2012-02-10       Impact factor: 3.582

5.  The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells.

Authors:  X Q Wang; W A Frazier
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

6.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes.

Authors:  M P Skinner; E W Raines; R Ross
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells.

Authors:  M M Zutter; S A Santoro; W D Staatz; Y L Tsung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Extracellular matrix proteins and integrin receptors in reactive and non-reactive lymph nodes.

Authors:  E Castaños-Velez; P Biberfeld; M Patarroyo
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

10.  In situ expression of beta 1, beta 3 and beta 4 integrin subunits in non-neoplastic endothelium and vascular tumours.

Authors:  G Mechtersheimer; T Barth; W Hartschuh; T Lehnert; P Möller
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.